These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 20191499
1. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjögren's syndrome. Virkki LM, Porola P, Forsblad-d'Elia H, Valtysdottir S, Solovieva SA, Konttinen YT. Arthritis Care Res (Hoboken); 2010 Jan 15; 62(1):118-24. PubMed ID: 20191499 [Abstract] [Full Text] [Related]
2. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial. Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, Derksen RH. Ann Rheum Dis; 2008 Jan 15; 67(1):91-7. PubMed ID: 17545193 [Abstract] [Full Text] [Related]
5. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC. Arthritis Rheum; 2004 Aug 15; 51(4):601-4. PubMed ID: 15334433 [Abstract] [Full Text] [Related]
6. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H. Arthritis Rheum; 2010 Apr 15; 62(4):960-8. PubMed ID: 20131246 [Abstract] [Full Text] [Related]
7. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH. Ann Rheum Dis; 2010 Jun 15; 69(6):1144-7. PubMed ID: 19854713 [Abstract] [Full Text] [Related]
8. Fatigue and blood pressure in primary Sjogren's syndrome. d'Elia HF, Rehnberg E, Kvist G, Ericsson A, Konttinen Y, Mannerkorpi K. Scand J Rheumatol; 2008 Jun 15; 37(4):284-92. PubMed ID: 18612929 [Abstract] [Full Text] [Related]
9. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome. Hartkamp A, Geenen R, Bijl M, Kruize AA, Godaert GL, Derksen RH. Ann Rheum Dis; 2004 Oct 15; 63(10):1335-7. PubMed ID: 15361396 [Abstract] [Full Text] [Related]
10. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome. Laine M, Porola P, Udby L, Kjeldsen L, Cowland JB, Borregaard N, Hietanen J, Ståhle M, Pihakari A, Konttinen YT. Arthritis Rheum; 2007 Aug 15; 56(8):2575-84. PubMed ID: 17665393 [Abstract] [Full Text] [Related]
11. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J. Arthritis Rheum; 2004 Apr 15; 50(4):1270-6. PubMed ID: 15077311 [Abstract] [Full Text] [Related]
12. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P. Ann Rheum Dis; 2008 Nov 15; 67(11):1541-4. PubMed ID: 18276741 [Abstract] [Full Text] [Related]
13. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Cleare AJ, O'Keane V, Miell JP. Psychoneuroendocrinology; 2004 Jul 15; 29(6):724-32. PubMed ID: 15110921 [Abstract] [Full Text] [Related]
14. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. Valtysdóttir ST, Wide L, Hällgren R. J Rheumatol; 2001 Jun 15; 28(6):1259-65. PubMed ID: 11409117 [Abstract] [Full Text] [Related]
15. Measuring fatigue among women with Sjögren's syndrome or rheumatoid arthritis: a comparison of the Profile of Fatigue (ProF) and the Multidimensional Fatigue Inventory (MFI). Goodchild CE, Treharne GJ, Booth DA, Kitas GD, Bowman SJ. Musculoskeletal Care; 2008 Mar 15; 6(1):31-48. PubMed ID: 18085596 [Abstract] [Full Text] [Related]
16. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome. Porola P, Virkki L, Przybyla BD, Laine M, Patterson TA, Pihakari A, Konttinen YT. J Rheumatol; 2008 Nov 15; 35(11):2229-35. PubMed ID: 18843777 [Abstract] [Full Text] [Related]
17. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis. Ahboucha S, Pomier-Layrargues G, Vincent C, Hassoun Z, Tamaz R, Baker G, Butterworth RF. Neurochem Int; 2008 Nov 15; 52(4-5):569-74. PubMed ID: 17669554 [Abstract] [Full Text] [Related]
18. Effects of a gliadin-combined plant superoxide dismutase extract on self-perceived fatigue in women aged 50-65 years. Houghton CA, Steels EL, Fassett RG, Coombes JS. Phytomedicine; 2011 Apr 15; 18(6):521-6. PubMed ID: 21044831 [Abstract] [Full Text] [Related]
19. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome. Walker J, Gordon T, Lester S, Downie-Doyle S, McEvoy D, Pile K, Waterman S, Rischmueller M. J Rheumatol; 2003 Nov 15; 30(11):2406-12. PubMed ID: 14677185 [Abstract] [Full Text] [Related]